NEW THERAPEUTIC AGENTS MARKETED IN FIRST HALF OF 2010 P53 NOVEMBER 010 VOLUME 16, NUMBER 11 Visit www.pharmacytoday.org New oral agent for relapsing MS Psychiatric disorders: 340B can help FDA working to ensure medication safety 29 35 40 44 W. A A I T. Managing your MTM practice as it grows Brad Tice advances MTM the PharmMD way 45 A A AY